Board declares Interim Dividend
Fredun Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 31, 2016, have decided to presently cancel the matter of issuing the Equity shares of the Company to the Investors under the Preferential Guidelines.Further, The Board of Directors of the Company at their meeting held on March 31, 2016 have declared an Interim Dividend of 0.60 paise (6%) per share for the year ending March 31, 2016. Board to consider Interim Dividend
Fredun Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on March 31, 2016, to consider the following matter:1. To declare the Interim Dividend.2. To discuss, consider and approve the issue of Equity shares of the Company to the investors under the preferential Guidelines. Shareholding for the Period Ended December 31, 2015
Fredun Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click here Standalone Financial Results, Limited Review Report for December 31, 2015
Fredun Pharmaceuticals Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20152. Standalone Limited Review for the period ended December 31, 2015 Listing of equity shares of Fredun Pharmaceuticals Ltd
Trading Members of the Exchange are hereby informed that effective from March 21, 2016, the equity shares of Fredun Pharmaceuticals Ltd (Scrip Code: 539730) are listed and admitted to dealings on the Exchange in the list of 'XT' Group Securities. For further details please refer to the notice no 20160317-10 dated March 17, 2016.